Lamivir (Stavudine and Lamivudine) Tablets

Lamivir (Stavudine and Lamivudine) Tablets

Brand Name: Lamivir S-40 / Lamivir S-30
Contents: Stavudine 40mg and Lamivudine 150mg / Stavudine 30mg and Lamivudine 150mg
Form: Tablets
Manufacturer Cipla India Ltd
Packing: Pack of 60 tabs

INDICATIONS

LAMIVIR-S tablets are indicated for the treatment of HIV infection as a component of combination antiretroviral therapy.

DOSAGE AND ADMINISTRATION

The interval between doses of Lamivir S should be 12 hours. Lamivir S may be taken with or without food.

Adults

LAMIVIR-S – 30 1 tablet twice daily for patients weighing <60 kg Dose adjustment: Because it is a fixed-dose combination, LAMIVIR-Sshould not be prescribed for patients requiring dosage adjustment, such as those with reduced renal function (creatinine clearance ≤ 50 ml/min), or those experiencing dose-limiting adverse events.

CONTRAINDICATION

S LAMIVIR-S is contraindicated in patients with clinically significant hypersensitivity (anaphylaxis) to any of the components of the product.

PACKAGING INFORMATION

LAMIVIR S – 40 ……………….. Container of 60 tablets